Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sandoz Issues Recall of Losartan Potassium, Hydrochlorothiazide

americanpharmaceuticalreviewNovember 10, 2018

Tag: hypertension , Losartan Potassium , Sandoz , hypertension

PharmaSources Customer Service